High density lipoprotein subfractions during continuous insulin infusion therapyHELVE, E.Atherosclerosis. 1987, Vol 64, Num 23, pp 173-180, issn 0021-9150Article

Comparison of lovastatin and probucol in treatment of familial and non-familial hypercholesterolemia: different effects on lipoprotein profilesHELVE, E; TIKKANEN, M. J.Atherosclerosis. 1988, Vol 72, Num 2-3, pp 189-197, issn 0021-9150Article

Improvement of diabetic control by continuous subcutaneous insulin infusion therapy changes fatty acid composition of serum lipids and erythrocytes in type 1 (insulin-dependent) diabetesTILVIS, R. S; HELVE, E; MIETTINEN, T. A et al.Diabetologia (Berlin). 1986, Vol 29, Num 10, pp 690-694, issn 0012-186XArticle

Effects of continous insulin infusion therapy on lipoprotein surface and core lipid composition in insulin-dependent diabetes mellitusBAGDADE, J. D; HELVE, E; TASKINEN, M.-R et al.Metabolism, clinical and experimental. 1991, Vol 40, Num 5, pp 445-449, issn 0026-0495Article

Lovastatin and gemfibrozil in the treatment of type 2a and type 2b hyperlipoproteinemiaTIKKANEN, M. J; OJALA, J.-P; HELVE, E et al.European journal of clinical pharmacology. 1991, Vol 40, pp S23-S25, issn 0031-6970, SUP1Conference Paper

Smoking and insulin sensitivity in type I diabetic patientsHELVE, E; YKI-JARVINEN, H; KOIVISTO, V. A et al.Metabolism, clinical and experimental. 1986, Vol 35, Num 9, pp 874-877, issn 0026-0495Article

Hyperglycemia decreases glucose uptake in type I diabetesYKI-JARVINEN, H; HELVE, E; KOIVISTO, V. A et al.Diabetes (New York, NY). 1987, Vol 36, Num 8, pp 892-896, issn 0012-1797Article

Captopril does not acutely enhance insulin sensitivityHELVE, E; TUOMINEN, J. A; KOIVISTO, V. A et al.Journal of internal medicine. 1993, Vol 234, Num 1, pp 41-44, issn 0954-6820Article

Simvastatin and gemfibrozil in the treatment of primary hypercholesterolemiaHELVE, E; OJALA, J.-P; TIKKANEN, M. J et al.Journal of applied cardiology. 1988, Vol 3, Num 6, pp 381-388, issn 0883-2935Article

Relationship between oral glucose tolerance and insulin sensitivity in healthy man and type 1 diabetic patientsYKI-JARVINEN, H; HELVE, E; KOIVISTO, V. A et al.Acta endocrinologica (Oslo). 1986, Vol 112, Num 3, pp 355-360, issn 0001-5598Article

Treatment of combined hyperlipidemia with lovastatin versus Gemfibrozil : a comparison studyOJALA, J.-P; HELVE, E; TIKKANEN, M. J et al.Cardiology. 1990, Vol 77, pp 39-49, issn 0008-6312, 11 p., SUP4Conference Paper

Bedtime insulin for suppression of overnight freèfatty acid. blood glucose, and glucose production in NIDDMTASKINEN, M.-R; SANE, T; HELVE, E et al.Diabetes (New York, NY). 1989, Vol 38, Num 5, pp 580-588, issn 0012-1797Article

Effect of apolipoprotein E polymorphism and Xbal polymorphism of apolipoprotein B on response to lovastatin treatment in familial and non-familial hypercholesterolaemiaOJALA, J.-P; HELVE, E; EHNHOLM, C et al.Journal of internal medicine. 1991, Vol 230, Num 5, pp 397-405, issn 0954-6820Article

The adjustment of diet and insulin dose during long-term endurance exercise in type I (insulin-dependent) diabetic menSANE, T; HELVE, E; PELKONEN, R et al.Diabetologia (Berlin). 1988, Vol 31, Num 1, pp 35-40, issn 0012-186XArticle

Glucose and lipid metabolism and insulin sensitivity in type 1 diabetes: the effect of guar gumEBELING, P; YKI-JARVINEN, H; ARO, A et al.The American journal of clinical nutrition. 1988, Vol 48, Num 1, pp 98-103, issn 0002-9165, 6 p.Article

No association between retinopathy and insulin resistance in type 1 diabetesYKI-JARVINEN, H; HELVE, E; LAATIKAINEN, L et al.Acta endocrinologica (Oslo). 1986, Vol 111, Num 4, pp 522-527, issn 0001-5598Article

Pathogenesis and prevention of the dawn phenomenon in diabetic patients treated with CSIIKOIVISTO, V. A; YKI-JARVINEN, H; HELVE, E et al.Diabetes (New York, NY). 1986, Vol 35, Num 1, pp 78-82, issn 0012-1797Article

Long-term use of lovastatin in different types of hyperlipidaemiaTIKKANEN, M. J; OJALA, J.-P; HELVE, E et al.Atherosclerosis. 1992, Vol 97, pp S27-S32, issn 0021-9150, SUPConference Paper

Use of polymerase chain reaction to defect heterozygous familial hypercholesterolemiaKEINAÊNEN, M; OJALA, J.-P; HELVE, E et al.Clinical chemistry (Baltimore, Md.). 1990, Vol 36, Num 6, pp 900-903, issn 0009-9147, 4 p.Article

Finnish type of low density lipoprotein receptor gene mutation (FH-Helsinki) deletes exons encoding the carboxy-terminal part of the receptor and creates an internalization-defective phenotypeAALTO-SETATA, K; HELVE, E; KOVANEN, P. T et al.The Journal of clinical investigation. 1989, Vol 84, Num 2, pp 499-505, issn 0021-9738Article

Insulin inhibition of overnight glucose production and gluconeogenesis from lactate in NIDDMYKI-JARVINEN, H; HELVE, E; SANE, T et al.American journal of physiology. Endocrinology and metabolism. 1989, Vol 19, Num 6, pp E732-E739, issn 0193-1849Article

A crossover comparison of continuous insulin infusion and conventional injection treatment of type I diabetesHELVE, E; KOIVISTO, V. A; LEHTONEN, A et al.Acta medica Scandinavica. 1987, Vol 221, Num 4, pp 385-393, issn 0001-6101Article

Treatment of hypercholesterolemia and combined hyperlipidemia with simvastatin and gemfibrozil in patients with NIDDM a mu1ticenter comparison studyTIKKANEN, M. J; KAARSALO, E; LAAKSO, M et al.Diabetes care. 1998, Vol 21, Num 4, pp 477-481, issn 0149-5992Article

One-year response to evening insulin therapy in non-insulin-dependent diabetesSANE, T; HELVE, E; YKI-JÄRVINEN, H et al.Journal of internal medicine. 1992, Vol 231, Num 3, pp 253-260, issn 0954-6820Article

Long-term maintenance of therapeutic response to lovastatin in patients with familial and non-familial hypercholesterolemia : a 3-year follow-upOJALA, J.-P; HELVE, E; KARJALAINEN, K et al.Atherosclerosis. 1990, Vol 82, Num 1-2, pp 85-95, issn 0021-9150, 11 p.Article